Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
It’s here https://twitter.com/nihr_industry/status/1370679172562030596?s=21
References a news article from 2020
This is definitely something to keep an eye on over the next few days. The WTO will be discussing waving IP rights for COVID-19 vaccines and treatments . For obvious reasons this is being strongly apposed by western countries and big pharmaceutical companies. Due to be debated in the 10 and 11th:
https://www.fdanews.com/articles/201759-phrma-calls-on-biden-to-defend-us-intellectual-property-rights-for-covid-19-products
Apologies if already posed.
Thanks for sharing halfback. If p3 is successful then I’m pretty confident several governments will stockpile us. 100 days from strain identification to vaccine roll out was an interesting point. With the number of strains emerging right now this is going to be like a game of whack-a-mole. Add another 150 days to vaccinate on top of that and we will probably end up with an annual rolling vaccine. Let’s just hope it’s enough to stop the lockdowns!
How does it not? You might have noticed we are in the middle of a pandemic. You might have also noticed that Synairgen offer a treatment for said virus causing the pandemic. Running a music festival in a pandemic might be a bad idea. Glad we cleared this up.
Reading and Leeds boss 'very confident' festivals will happen https://www.bbc.co.uk/news/entertainment-arts-56185142
The same festival owners probably sold there Synairgen shares yesterday too :)
Tiger, 66% effective so not a patch on any of the other vaccines. Portable and easier to administer but less effective. When I’m eventually called up to get the vaccine I hope it’s not J and J’s! Won’t touch the SP.
https://twitter.com/erictopol/status/1364572270933336064?s=21 Our Friend Eric agrees!
It was just people panicking today. A few pi’s sold out causing a domino effect. The mms made a killing on the spread so were lapping it up. Most of those who sold will be back in in a few days once the vaccine news drifts away again. Pretty confident we will be in £2 territory by next week.
Well its good news for Synairgen but not for the world. A successful vaccine strategy needs reduction in cases as well as a reduction in people who progress to severe illness. If vaccines don’t help reduce numbers we will be in and out of lockdowns for the foreseeable future.
This is quite worrying:
https://www.bbc.co.uk/news/health-56098313
“But the researchers say they could not find any evidence of Covid vaccines having an impact on infection numbers, although signs may be visible by the time the final report is released in a matter of weeks, when a larger proportion of people will have been given protection.“
Activ 2 US Anouncement - Next 3 trading days
Home trial results- they will know - 25th Feb - RNS read out 20-25 March
Last dosing P3 - 6 weeks from start - 24-30 Feb
P3 RNS read out- 23-28th April
US EUA - next three weeks
Pre orders, Take over bid, Licensing deals - could land any day.
India TO - who knows, ask PMarrin!
It certainly feels like we are heading into Synairgen’s golden hour and we will start to see some significant SP increases when any of this news drops. Anything I’ve missed?
Full press release here: https://ir.novavax.com/news-releases/news-release-details/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3
Only 60% effective on SA variant though.
Let’s hope the US announce our inclusion in warp speed tomorrow so we get a bit of positive sp movement too!
New Covid vaccine shows 89% efficacy in UK trials https://www.bbc.co.uk/news/uk-55850352
Should be baked into the sp by now. But you never know with SNG
I feel your pain Mr Big. I need to dig that out for you in incognito mode. Found her profile a few months ago when checking out Proactives credentials. Kept me occupied for a little longer than it should :-)
Just for you Mr Big https://www.instagram.com/katie.pilbeam/?hl=en
;-)
A new trial funded by NIHR will look at reducing the transmission of Covid-19 and its severity in care homes.
Researchers led by the University of Nottingham are now looking for up to 400 care homes to take part in the ground-breaking trial - called PROTECT.
As part of the trial, they will test drugs that already show promise for treating Covid-19, but use them to prevent Covid-19 instead. They are focussing on care home residents due to their higher risk from Covid-19, and although priority has been given to them for vaccination, the effectiveness of vaccines in this group has not yet been fully established. The aim is to reduce the number and severity of Covid-19 in those homes.
The UK has more than 21,000 care homes looking after 420,000 residents, many of whom have dementia or physical care needs. Up to half of all Covid-19 deaths in the UK have occurred in care homes. If PROTECT can identify an effective drug to reduce transmission and severity of the virus, then this, alongside other measures, could help enable a return to a more normal life for residents and their families, including more liberal visiting policies.
Lead researcher, Professor Philip Bath, said: “Apart from vaccines, there are no drugs for preventing serious Covid-19 and we believe that the PROTECT trial has a good chance of finding one or more drugs that might reduce the awful death rates seen in care homes.”
The £1.7m trial will have a ‘platform’ structure, like the RECOVERY trial, which which has rapidly evaluated candidate treatments for Covid-19 and previously found that dexamethasone reduced death in hospitalised patients with severe Covid-19.
However, PROTECT will randomise care homes (rather than individual residents) to one of up to three drugs or no additional treatment, in a cluster randomised controlled design.
This design allows several drugs to be tested in parallel and for new drugs to be added once older ones have been shown to be beneficial or have no useful effect. Treatment will be given alongside the ongoing vaccination programme.
Experts from the Universities of Edinburgh, Cambridge, Surrey and Warwick and University College London are also supporting the study.
Minister for Innovation Lord Bethell said: “Vulnerable care homes residents have been disproportionately impacted by this virus and we are working tirelessly to find effective ways of protecting those most at risk.
“This is a very promising development for the UK and I actively urge as many care homes as possible to get involved with this trial, which the government is backing through the National Institute for Health Research.
“Together, we can play a part in helping to ensure the most vulnerable in our society are given every possible form of defence against the virus.”
Update published on their website earlier today looking for care homes to take part. Lord Bethell is involved, so maybe his tweet suggesting our trial was government funded had some meaning.
https://www.nihr.ac.uk/news/new-trial-to-test-drugs-for-preventing-covid-19-in-care-homes/26684
Wouldn’t be surprised if we were one of the first drugs to be tested.